REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMXC.L Share News (MXC)

  • There is currently no data for MXC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Lords sells business; Atome wins joint venture deal

Thu, 02nd Feb 2023 19:39

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Lords Group Trading PLC - London-based distributor of building, plumbing, heating and DIY goods - Reports the sale of its subsidiary Lords at Home Ltd for GBP805,000 to the current managing director of the business. During 2022, Lords at Home generated revenue of GBP3.0 million and contributed earnings before interest, tax, depreciation, and amortisation of GBP80,000, it says. "I am confident that the sale of Lords at Home Ltd is a good outcome for all stakeholders across both Lords Group Trading Plc and Lords at Home Ltd. We are confident that under its new ownership, Lords at Home will uphold its customer and colleague first approach. As a group we are focused on disciplined capital allocation to deliver strategic growth and the divestment of Lords at Home reflects this approach," Chief Executive Shanker Patel comments.

----------

Streaks Gaming PLC - London-based 'conversational gaming' products provider - Enters an advertising partnership with FanDuel, a sportsbook in the US. Does not disclose the financial value of the contract. "We are thrilled to be partnering with FanDuel. Their reputation and reach in the sports betting industry will allow us to further enrich the Streaks ecosystem, giving users greater choice and access to a wider selection of rewards for first time deposits on multiple platforms. We also believe this will have a positive impact on our revenue per customer as the customer base matures," CEO Mark Rutledge says.

----------

Tintra PLC - Windsor, Berkshire-based firm building banking and infrastructure technology systems - Notes that it received an update from the US Patent & Trademark Office on patent applications. Says that the office has now indicated the original filings for the two patents contained multiple inventions and not single ones as originally expected. Says that it has sought independent patent protection for each of the different inventions. "Due to the highly innovative and complex nature of the infrastructure that we are creating to enable future regulated identity systems, using web 3.0 technology, we were aware that there would be a requirement for multiple inventions to be ultimately filed. This positive feedback from the USPTO has now confirmed these initial thoughts, and this now gives us a strong base from which my team can build our web 3.0 patent portfolio upon, which based on this news today we now expect to be adding to significantly over the coming months," Chief Innovation Officer Davy Smith says.

----------

Atome Energy PLC - Leeds, England-based producer and marketer of green hydrogen and ammonia - Enters into a joint venture deal with Cavendish to develop green ammonia and fertiliser projects with focus on Central America and the Caribbean. The new joint enterprise is called National Ammonia Corporation SA. "We are excited as to the potential of NAC. The establishment of NAC shows the clear intent of ATOME to deploy its innovative business model and know-how in other geographies. With the Villeta Project in Paraguay, we have taken a significant industry lead that we are able to roll out and replicate under the right conditions. Our partnership with Cavendish, a company established by the founders and owners of Grupo Purdy, offers ATOME a very attractive opportunity with a strong local partner to accelerate the development of a pipeline of international scale projects with strong local demand for green fertilisers," CEO Olivier Mussat says.

----------

Smarttech247 Group PLC - managed detection & response company - Wins "a number" of new multi-year contracts with its automated managed detection and response platform. This includes a three-year agreement with a large US tech company and a two-year agreement with a "prestigious university in Ireland" worth USD400,000 and USD450,000 respectively over the lives of the contracts. "We look forward to working in partnership to provide improved security solutions to all our customers and will update the market on future progress in due course," CEO Raluca Saceanu comments.

----------

Pembridge Resources PLC - London-based copper-focused mining company - Notes that Minto Metals found multiple "high-grade" copper intersections from follow-up drilling at Minto North Including 1.91% copper over 34.59 metres. It holds a strategic investment in the Minto copper and gold mine in Yukon Territory. "These results are encouraging, giving Minto confidence to continue drilling at Minto North with an expectation of increasing mineral inventory," CEO Gati Al-Jebouri comments.

----------

Heathrow Airport - main international airport serving London, England - Says its Chief Executive John Holland-Kaye will stand down during 2023. He has been in the position since 2014. "John has been an extraordinary leader of Heathrow. During the past nine years, he has worked tirelessly and collaboratively with shareholders, ministers, airlines and other stakeholders to ensure the country can be proud of its 'front door'. The board would like to put on record our gratitude to John for his dedication and commitment to Heathrow throughout his tenure as CEO," Chair Deighton says.

----------

Panther Metals PLC - Mineral exploration company focused in Canada - Discovers additional volcagenic massive sulphide mineral system at its Obonga project. "Confirmation that the Obonga greenstone belt contains high-grade zinc grades at potentially commercial intervals is a defining moment for Panther Metals and its shareholders. We took control of nearly 90% of this greenstone belt, located just a 2.5 hour drive from the major port of Thunder Bay, due to the scale and exploration opportunity rarely witnessed, or available, in a tier one mining jurisdiction today," CEO Darren Hazelwood comments.

----------

Block Energy PLC - London-based oil and gas company focused in Georgia - Closes a senior secured loan facility of USD 1.1 million. Says that the funds will provide the company with additional headroom to accelerate its project I development programme. "The loan facility will allow Block to accelerate its Project I development programme, with the aim of increasing near-term cashflows, without the need for dilutive financing. It also means Block can acquire long-lead items, required for the drilling of additional sidetracks and wells on the West Rustavi/Krtstanisi field. This loan facility strengthens our position going into a busy 2023, when we aim to increase production from project I and progress our other three projects," Chair Phil Dimmock says.

----------

Hurricane Energy PLC - Surrey-based oil and gas producer in fields offshore west of Shetland - Confirms that the sealed court order confirming the reduction of capital and the associated statement of capital was approved by the High Court on January 31. Confirms that following the reduction of capital, the issued share capital of the company remains at 2 million ordinary shares of GBP0.001 each. "The registering of the court order with the Registrar of Companies will complete the reduction of capital process, which allows the company to make capital returns to shareholders. The completion of the process does not itself automatically trigger a capital return and, as previously announced, the next steps in terms of timing and exact quantum of a return of capital to shareholders will be decided in conjunction with the ongoing formal sales process and we look forward to updating shareholders in due course," Chair Philip Wolfe comments.

----------

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Executes a deed of variations with Mercer Street Global Opportunity Fund LLC for convertible securities agreements entered into between the company and Mercer in 2020 and 2022. This includes the refinancing of USD2.1 million worth of convertible securities which were due to mature in November 2. Extends maturing date by 15 months to February 1, 2024

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
1 Sep 2022 17:52

TRADING UPDATES: Strong interim results from Johnson Service, Eurocell

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Aug 2022 16:26

TRADING UPDATES: Malvern revenue jumps; Rockwood eyes Main Market

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
18 Aug 2022 11:57

IN BRIEF: Graft Polymer wins first commercial order for GraftBio

Graft Polymer (UK) PLC - London-based company focused on the development and production of polymer modification, biological supplements, and nano-drug delivery systems - Wins first commercial purchase order for its GraftBio division. Order for 50,000 units of its anti-inflammatory supplement, ArtemiC Rescue from MGC Pharmaceuticals PLC. Order worth around USD1 million. Production to start immediately. Delivery expected over the next three months. Chief Executive Victor Volduev says he expects follow-on orders in the coming quarters.

Read more
17 Aug 2022 11:12

MGC shares rise on USD1 million order for ArtemiC

(Alliance News) - MGC Pharmaceuticals Ltd shares were lifted on Wednesday after it announced a USD1 million order for its neutraceutical, ArtemiC.

Read more
15 Aug 2022 17:31

IN BRIEF: MGC Pharma's CannEpil found safe for driving in study

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says clinical study results for its epilepsy treatment, CannEpil, are complete. The study found CannEpil to be safe for post-treatment driving activities. It used a driving simulator to test whether the drug caused somnolence, ie drowsiness, or impairs cognition. It was sponsored by Cannvalate Australia, and conducted by the Centre of Human Psychopharmacology at Swinburne University of Technology, under the Medical Cannabis Research Collaboration.

Read more
5 Aug 2022 14:58

TRADING UPDATES: 4D Pharma warns of wind-up; Star Phoenix files claim

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and Wednesday and not separately reported by Alliance News:

Read more
29 Jul 2022 19:36

TRADING UPDATES: Walker Crips assets grow; Minoan interim loss narrows

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
28 Jul 2022 20:08

TRADING UPDATES: Scottish American outperforms; Amte picks Dundee

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
25 Jul 2022 21:53

IN BRIEF: MGC Pharmaceuticals quarterly sales "strong"

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says "strong" quarterly sales continue, notes AUD1.6 million, about GBP923,000, in cash receipts during three month period to June 30. In 12-month period, records AUD6.1 million in cash receipts.

Read more
14 Jul 2022 21:44

TRADING UPDATES: Shield closer to Canada approval; Angle plans raise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
8 Jul 2022 14:19

IN BRIEF: MGC Pharmaceuticals wins approval for Covid study, shares up

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Receives approval from South African Health Products Regulatory Authority for a Phase 2b dose finding study of its nanoparticle formulation CimetrA on patients diagnosed with Covid-19.

Read more
6 Jul 2022 20:08

IN BRIEF: MGC Pharmaceuticals launches medical data app ZAM

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says it is set to launch a real-time data collection application, ZAM, for use across the pharmaceutical and health care sectors, in collaboration with software development company, Caba Tech. The app will be available during the third quarter and will enable patients to log their medical history and monitor their medication use. ZAM, through the collection the patient data, will also provide users with a more complete understanding of their health and treatments, it says.

Read more
27 Jun 2022 20:27

IN BRIEF: MGC's CimetrA shows promise beyond Covid applications

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Says preliminary results from pre-clinical in vitro study of CimetrA show it could have "wide-ranging application" as anti-inflammatory treatment. This is through the treatment's modulation of the production of pro-inflammatory cytokines. The study was undertaken by Israeli contract research organisation, Science in Action. Results support previous findings from a 2020 study into Covid-19, which showed CimetrA modulates the body's production of cytokines, which can lead to a cytokine storm, a type of severe immune reaction. New results support the potential of CimetrA to have a wider-ranging application as anti-inflammatory treatment, beyond the treatment of Covid-19 symptoms.

Read more
24 Jun 2022 10:13

IN BRIEF: MGC Pharma moves ahead with Covid-19 treatment in US

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Progresses plans to begin US clinical trial for its Covid-19 treatment CimetrA, as MGC and AMC Holdings Inc executives meet with department heads from the University of South Florida. Parties also discuss regulatory approvals for phytocannabinoid medicines CogniCann and CannEpil in the US for early patient access schemes. Says US market access and distribution agreement has been signed with minimum orders of USD24 million over three years, including CimetrA.

Read more
16 Jun 2022 13:43

IN BRIEF: MGC Pharmaceuticals completes research study on brain cancer

MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Completes an in-vitro preclinical research study with the National Institute of Biology into the use of cannabinoids to treat brain cancer. The company says the study, undertaken on 30 biopsy samples from 18 patients over a period of three years, sought to determine the optimal formulation for the treatment of Glioblastoma, a form of brain cancer. The study showed that MGC Pharma's proprietary formulations were cytotoxic to Glioblastoma tumour and stem cells, reducing the cells' viability and inducing caspase-dependent cell apoptosis, or cell death.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.